Bristol-Myers Squibb Co [BMY] stock prices are up 1.20% to $45.36 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BMY shares have gain 4.73% over the last week, with a monthly amount drifted -4.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bristol-Myers Squibb Co [NYSE: BMY] stock has seen the most recent analyst activity on August 05, 2025, when Daiwa Securities downgraded its rating to a Neutral but kept the price target unchanged to $42 for it. On April 22, 2025, Cantor Fitzgerald initiated with a Neutral rating and assigned a price target of $55 on the stock. Jefferies upgraded its rating to a Buy but stick to its price target of $70 on December 16, 2024. In a note dated November 13, 2024, Daiwa Securities upgraded an Outperform rating on this stock.
The stock price of Bristol-Myers Squibb Co [BMY] has been fluctuating between $42.96 and $63.33 over the past year. Currently, Wall Street analysts expect the stock to reach $64.75 within the next 12 months. Bristol-Myers Squibb Co [NYSE: BMY] shares were valued at $45.36 at the most recent close of the market. An investor can expect a potential return of 42.75% based on the average BMY price forecast.
Analyzing the BMY fundamentals
The Bristol-Myers Squibb Co [NYSE:BMY] reported sales of 47.70B for trailing twelve months, representing a surge of 0.56%. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at 0.34%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.3 and Total Capital is 0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Bristol-Myers Squibb Co [NYSE:BMY]’s Current Ratio is 1.21. As well, the Quick Ratio is 1.11, while the Cash Ratio is 0.46. Considering the valuation of this stock, the price to sales ratio is 1.94, the price to book ratio is 5.29 and price to earnings (TTM) ratio is 18.30.
Transactions by insiders
Recent insider trading involved Short Bartie Wendy, EVP, Corporate Affairs, that happened on Aug 02 ’25 when 378.0 shares were sold. President, RayzeBio Org., Hickey Benjamin completed a deal on May 09 ’25 to sell 97.0 shares. Meanwhile, EVP,Chief Med.Offr.,Drug Dev. Hirawat Samit bought 4250.0 shares on Apr 25 ’25.
